Repligen Corporation
RGEN
$147.06
$6.054.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 204.13M | 194.26M | 197.91M | 188.81M | 182.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 204.13M | 194.26M | 197.91M | 188.81M | 182.37M |
| Cost of Revenue | 94.09M | 85.97M | 94.08M | 88.29M | 89.37M |
| Gross Profit | 110.04M | 108.28M | 103.83M | 100.52M | 93.00M |
| SG&A Expenses | 76.62M | 76.54M | 74.36M | 73.66M | 70.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 185.13M | 176.97M | 181.57M | 176.13M | 174.25M |
| Operating Income | 19.00M | 17.29M | 16.35M | 12.68M | 8.12M |
| Income Before Tax | 14.15M | 1.77M | 19.11M | 17.11M | 18.22M |
| Income Tax Expenses | 9.15M | -6.56M | 5.83M | 2.20M | 3.35M |
| Earnings from Continuing Operations | 5.01M | 8.33M | 13.29M | 14.91M | 14.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.01M | 8.33M | 13.29M | 14.91M | 14.87M |
| EBIT | 19.00M | 17.29M | 16.35M | 12.68M | 8.12M |
| EBITDA | 38.06M | 37.05M | 36.30M | 32.69M | 28.20M |
| EPS Basic | 0.09 | 0.15 | 0.24 | 0.27 | 0.26 |
| Normalized Basic EPS | 0.21 | 0.19 | 0.20 | 0.14 | 0.14 |
| EPS Diluted | 0.09 | 0.15 | 0.23 | 0.26 | 0.26 |
| Normalized Diluted EPS | 0.21 | 0.19 | 0.19 | 0.14 | 0.14 |
| Average Basic Shares Outstanding | 56.42M | 56.35M | 56.31M | 56.27M | 56.23M |
| Average Diluted Shares Outstanding | 56.64M | 56.67M | 56.66M | 56.53M | 56.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |